Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Global perspective of treatment failures.

Literature DB >> 24523834

Global perspective of treatment failures.

Abstract

Overactive bladder (OAB) is a highly prevalent condition, affecting approximately 18% of adult Canadians. The impact of OAB is substantial, negatively affecting quality of life, sexuality and work productivity. Furthermore, patients with OAB are at increased risk of several other important comorbidities, including mood and anxiety disorders. Despite widespread availability of efficacious treatment, research has shown that OAB remains underdiagnosed and undertreated.

Entities: Disease Species

Year: 2013 PMID： 24523834 PMCID： PMC3919186 DOI： 10.5489/cuaj.1613

Source DB: PubMed Journal: Can Urol Assoc J ISSN： 1911-6470 Impact factor: 1.862

15 in total

1. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal: Neurourol Urodyn Date: 2002 Impact factor: 2.696

2. The impact of OAB on sexual health in men and women: results from EpiLUTS.

Authors: Karin S Coyne; Chris C Sexton; Christine Thompson; Zoe S Kopp; Ian Milsom; Steven A Kaplan
Journal: J Sex Med Date: 2011-04-14 Impact factor: 3.802

3. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.

Authors: Ian Milsom; Steven A Kaplan; Karin S Coyne; Chris C Sexton; Zoe S Kopp
Journal: Urology Date: 2012-07 Impact factor: 2.649

1. Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review.

Authors: Gillian Yeowell; Philip Smith; Jameel Nazir; Zalmai Hakimi; Emad Siddiqui; Francis Fatoye
Journal: BMJ Open Date: 2018-11-21 Impact factor: 2.692

1 in total

Global perspective of treatment failures.

1. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

2. The impact of OAB on sexual health in men and women: results from EpiLUTS.

3. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.

4. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups.

5. Barriers to help seeking in people with urinary symptoms.

6. Employees with overactive bladder: work loss burden.

7. Prevalence of overactive bladder and incontinence in Canada.

8. Prevalence and physician awareness of symptoms of urinary bladder dysfunction.

9. Economic costs of overactive bladder in the United States.

10. Misconceptions and miscommunication among aging women with overactive bladder symptoms.

1. Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review.